Zydus Cadila gets USFDA nod for blood pressure drug
Zydus Cadila today said it has received USFDA approval to market Triamterene and Hydrochlorothiazide tablets, indicated to treat high blood pressure.
The approval has been granted for the tablets in strengths
Disclaimer: No Business Standard Journalist was involved in creation of this content